Pauls Matthew (CIK 1573429) reported 14 SEC Form 4 insider transactions across 3 companies over the past 18 months (most recent 2026-07-07). Recent activity: Sell PTHS (692 shares), Sell PTHS (94 shares), Sell SLNO (10,491 shares), Sell PTHS (415 shares), Sell PTHS (371 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-07-07 | Pelthos Therapeutics Inc. (PTHS) | Director | Sell | 692 | $17,989 |
| 2026-07-07 | Pelthos Therapeutics Inc. (PTHS) | Director | Sell | 94 | $2,572 |
| 2026-05-18 | SOLENO THERAPEUTICS INC (SLNO) | Director | Sell | 10,491 | $0 |
| 2026-04-06 | Pelthos Therapeutics Inc. (PTHS) | Director | Sell | 415 | $8,514 |
| 2026-04-06 | Pelthos Therapeutics Inc. (PTHS) | Director | Sell | 371 | $7,926 |
| 2025-12-16 | Savara Inc (SVRA) | CHIEF EXECUTIVE OFFICER | Sell | 195,705 | $1.4M |
| 2025-12-16 | Savara Inc (SVRA) | CHIEF EXECUTIVE OFFICER | Sell | 128,995 | $0 |
| 2025-12-12 | Pelthos Therapeutics Inc. (PTHS) | Director | Buy | 8,493 | $0 |
| 2025-12-12 | Pelthos Therapeutics Inc. (PTHS) | Director | Buy | 2,123 | $0 |
| 2025-12-12 | Pelthos Therapeutics Inc. (PTHS) | Director | Sell | 9,542 | $0 |
| 2025-12-11 | Savara Inc (SVRA) | CHIEF EXECUTIVE OFFICER | Sell | 23,629 | $0 |
| 2025-06-09 | SOLENO THERAPEUTICS INC (SLNO) | Director | Buy | 3,991 | $0 |
| 2025-03-31 | SOLENO THERAPEUTICS INC (SLNO) | Director | Buy | 5,937 | $27,310 |
| 2025-03-31 | SOLENO THERAPEUTICS INC (SLNO) | Director | Sell | 5,937 | $424,792 |
Source: SEC Form 4 filings · as of 2026-07-07